TELA Bio is suing Becton Dickinson for allegedly abusing its monopoly power in the hernia mesh market to limit competition ...

Oakmark Funds, advised by Harris Associates, released its “Oakmark Global Fund” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here. The fund returned -5.78% in the ...

Becton, Dickinson and Company BDX, popularly known as BD, recently announced a collaboration with the Institute for ...

In the last year, multiple insiders have substantially increased their holdings of Becton, Dickinson and Company (NYSE:BDX) ...

First Eagle Investments, an investment management company, released its “First Eagle Global Fund” second-quarter 2025 investor letter. A copy of the letter can be downloaded here. Class A shares of ...

We recently published a list of the 10 Best Dividend Monarchs to Invest in Now. In this article, we are going to take a look at where Becton, Dickinson and Company (NYSE:BDX) stands against other best ...

Becton Dickinson has been sued by a rival medical device manufacturer for allegedly thwarting competition in the U.S. market ...

Becton, Dickinson, and Company (BDX), based in Franklin Lakes, New Jersey, is a leading global medical technology firm dedicated to advancing healthcare through innovative medical devices, laboratory ...

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope ...

Testing companies have revealed little about how their products perform in minors. That could be a problem. By Katherine J. Wu The reversal came just hours after the federal government threatened the ...

Valued at a market cap of $57.1 billion, Becton, Dickinson and Company (BDX) is a global medical technology company that develops, manufactures, and sells medical supplies, devices, laboratory ...